echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Recently, medical institutions in Zhejiang Province announced 58 drug varieties in short supply

    Recently, medical institutions in Zhejiang Province announced 58 drug varieties in short supply

    • Last Update: 2016-03-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: on March 22-25, 2016, the Boao Forum for Asia annual meeting 2016 was held in Boao, Hainan Province, China Traditional Chinese medicine once again "speaks" to Boao Zhang Boli, academician of the Chinese Academy of engineering, President of the Chinese Academy of traditional Chinese medicine and President of Tianjin University of traditional Chinese medicine, said at the sub Forum on "scientific and technological innovation: boosting the internationalization of traditional Chinese medicine" on the afternoon of 23rd that traditional Chinese medicine is the great creation of the Chinese nation and the key to opening the treasure house of Chinese civilization But it is not closed It should keep pace with the times and develop constantly In order to better serve the world's people's health, it is necessary to practice "internal skill", increase scientific and technological innovation, make its "wings" harder, and formulate relevant standards to standardize and promote the international development of traditional Chinese medicine In recent years, with the advent of aging society, the disease spectrum of Chinese people has also changed, and the prevalence of chronic non infectious diseases such as ischemic heart disease, stroke, tumor and other diseases has increased significantly "While these diseases bring sufferings to patients, they also increase medical expenses and form a vicious circle." Zhang Boli said, "the purpose of medicine should be to discover and develop people's self-health ability, which should be changed from" treating diseases "to" preventing diseases " Traditional Chinese medicine has always advocated treating diseases before they become ill, which conforms to the concept and direction of the development of modern medicine, and has been widely respected and recognized by the society." "But in order to go to the world and be accepted by the people of the world, we need to strengthen scientific and technological innovation and improve the technical content of traditional Chinese medicine." Said Zhang Boli In recent years, as the State Council and relevant ministries and commissions have repeatedly issued documents to promote the "going out" of traditional Chinese medicine, traditional Chinese medicine has spread to more than 170 countries and regions in the world, and signed nearly 100 intergovernmental agreements with more than 70 countries containing traditional Chinese medicine "China has established more than 10 centers of traditional Chinese medicine abroad, and another 10 will be established this year to become a base for overseas development of traditional Chinese medicine," Zhang said If we want to continue to deepen the internationalization of traditional Chinese medicine, we need to use scientific and technological means to present the efficacy of traditional Chinese medicine We need to help traditional Chinese medicine tell "stories" and tell the people of the world why and how it works " In 2015, Tu Youyou, a Chinese scientist, won the 2015 Nobel Prize in physiology or medicine for her research results on artemisinin "This award is awarded to the achievement of combining the experience, wisdom and Inspiration of traditional Chinese medicine with modern science Tu youyou discovered artemisinin and made great contribution to human health, which is really worthy of his name," said Zhang Boli Traditional Chinese medicine has accumulated for thousands of years, which can be said to be a "treasure house not yet fully developed" It needs to be explored and improved with science and technology " In addition, Zhang Boli stressed that "the internationalization of traditional Chinese medicine still needs to establish relevant standards as soon as possible Now a number of standards in China have been widely recognized and applied in the world, such as the education standard of traditional Chinese medicine has been 50 Six countries have adopted and now have completed the compilation of Chinese textbooks for traditional Chinese medicine, which are commonly used in the world This year, the compilation of English will be carried out, and the editorial board has been established At the same time, some quality standards of traditional Chinese medicine have also been internationally recognized For example, 27 quality standards of 9 varieties of Salvia miltiorrhiza have been officially adopted by USP, and 99 varieties of traditional Chinese medicine are being reviewed and approved by USP China is in the process of reaching an agreement with the EU to jointly draft a monograph on this draft, which will also provide useful support for the entry of traditional Chinese medicine into the EU market " Recently, medical institutions in Zhejiang Province announced the source of 58 drug varieties in short supply: Cyprian blue collated On March 25, 2016, Zhejiang Pharmaceutical Machinery Procurement Center issued the notice of "strengthening transaction management and sorting out the shortage", and announced 58 drug varieties in short supply Different from other provinces, Zhejiang Province has analyzed three reasons for the shortage of products in detail, and has taken different countermeasures For the varieties that have not been guaranteed supply, it is required that enterprises implement the responsibility of drug security There was no mention of the specific measures to be taken According to the notice issued by Zhejiang Pharmaceutical machinery purchasing center, the shortage of drugs is as follows: first, some drugs have been restored to normal supply In the early stage, our center sorted out the products by verifying the reasons for the shortage Such as sorting out and adjusting the reference price of low-cost drug products according to the rules, adjusting the purchase price according to the actual market supply, including some drugs into the system management of drugs with tight supply, such as fluorouracil injection, phensulfoethylamine injection, etc., and requiring enterprises to actively organize the source of goods to ensure the drug demand of medical institutions Second, some drugs are out of stock During the verification, it was found that some products were out of stock in some areas For example, the distribution rate of cefuroxime ester tablets (specification: 0.25g * 12 tablets / box) produced by Glaxo operations UK Limited in the United Kingdom is lower than 60% in Zhoushan, Ningbo and Taizhou, and above 90% in other cities As the first person responsible for the supply, the winning manufacturer shall log in to the trading platform to check the purchase and distribution of the winning products, coordinate the supply work and ensure the supply of drugs traded online Agencies at all levels should also urge distribution enterprises in the region to actively organize sources of goods Third, some drugs are out of stock at different stages due to production line transformation and expiration of import approval documents During the verification, it was found that some enterprises had fed back the actual production and supply situation to the relevant distribution enterprises, but did not feed back the situation to the medical institutions in time For example, haloperidol decanoate injection produced by Atlantic Laboratories Corporation, Ltd in Thailand Fourth, some reasons for shortage need to be further verified and sorted out In case of insufficient supply and phased supply difficulties in the supply of bid winning manufacturers which may affect the drug demand of medical institutions, relevant information shall be fed back to the medical institutions and distribution enterprises in time to facilitate the supply of information and ensure the supply of bid winning drugs For the products that have not been solved the shortage problem, our center will strengthen the supervision and implement the main body of responsibility for the shortage drugs Attachment: out of stock products declared by recent medical institutions
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.